MARKETSnap
  • Market Snapshots
    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
    • P/E Ratios
      • Large Caps
      • Absolute
      • Total Market PE
    • Stocks Performance
      • Large Caps
      • Absolute
    • Industries Performance
      • Industry
      • Sector
  • Analyze Stock
    • Analyze a stockAnalyze QDEL →
    • FindStock Picks / Stock Screener
    • Value · QDELIntrinsic Value Calculator
    • Invest · QDELInvestment Case
    • Hold · QDEL5-Year Outlook
  • Learn
  • Calendar
  • Investment Compounding
    Calculator
  • Investing Philosophy
  • More
    • Charts
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
QDEL stock logo

QDEL

QuidelOrtho Corporation

$8.32
-0.6
 (-6.73%)
Exchange:  NASDAQ
Market Cap:  570.857M
Shares Outstanding:  67.8M
Delayed data
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  HealthcareView sector performance
Industry:  Medical – SpecialtiesView industry performance
   
CEO:  Brian J. Blaser
Full Time Employees:  6500
Address: 
9975 Summers Ridge Road
San Diego
CA
92121
US
Website:  https://www.quidelortho.com
QuidelOrtho Corporation specializes in the creation and production of diagnostic testing solutions, addressing a wide array of healthcare testing demands. The company operates through distinct business units. Its Labs division provides clinical chemistry and immunoassay instruments and tests designed to analyze bodily fluids and proteins, aiding in health assessment, patient management, and tracking disease progression. The Transfusion Medicine unit focuses on ensuring blood safety and compatibility by offering immunohematology and infectious disease screening tests for blood and plasma. For rapid results in various clinical environments, the Point-of-Care segment delivers quick diagnostic tests. Additionally, the Molecular Diagnostics arm develops advanced polymerase chain reaction thermocyclers, analyzers, and amplification systems. QuidelOrtho distributes its offerings both directly to end-users and through an extensive network of distributors. These products are utilized by professionals in settings such as medical offices, hospitals, clinical and reference laboratories, urgent care centers, universities, retail clinics, pharmacies, wellness screening centers, and blood/donor banks, as well as for individual, non-professional, and over-the-counter applications. Founded in 1979 and based in San Diego, California, the company maintains a global footprint, including operations across North America, Europe, the Middle East, Africa, and China.

Click to read more…

Revenue Segmentation

Revenue by type

Revenue by region

Log in to continue

Log in to see the complete revenue and geographic breakdown.

Log in — it's free

Industry Peers

TICKERCOMPANYMKT CAPP/EFWD P/EROIC
QDQDEL logoQDELQuidelOrtho Corporation570.9M—12.4-2.4%
VVVVVV logoVVVVvVARDIS HOLDING AG Class A558.7M———
MLMLAB logoMLABMesa Laboratories, Inc.719.0M10814.13.6%
SISI logoSIShoulder Innovations, Inc.421.6M——-26.3%
MOMOBI logoMOBIMobia Medical, Inc. Common Stock394.5M——-40.7%
MAMASS logoMASS908 Devices Inc.360.5M——-16.0%

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Log in — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2026/05/06 — Q1 quarter 2026

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Log in — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue2,997,8002,782,9002,730,200
Gross Profit1,497,1001,286,5001,274,200
EBITDA607,000-1,489,800-488,100
Operating Income139,100-1,960,900-919,200
Net Income-10,100-2,052,000-1,131,800

Log in to continue

Log in to see the income statement and 10 historical years.

Log in — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets8,563,1006,423,6005,769,300
Total Liabilities3,557,2003,439,1003,848,800
Total Stockholders Equity5,005,9002,984,5001,920,500
Total Debt2,614,1002,681,4002,804,600
Cash and Cash Equivalents118,90098,300169,800

Log in to continue

Log in to see the balance sheet and 10 historical years.

Log in — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow280,20083,000105,200
Capital Expenditure-209,300-195,100-188,200
Free Cash Flow70,900-112,100-83,000
Net Income-10,100-2,052,000-1,131,800
Net Change in Cash-174,400-21,00071,300

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Log in — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2030Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Low)2,798,184.078Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (High)2,847,960.154Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Avg)2,825,772Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Low)557,287.782Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (High)559,108.405Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Avg)558,296.589Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Low)60,245.724Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (High)61,643.082Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Avg)61,020Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Low)635,005.750Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (High)646,301.681Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Avg)641,266.413Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Avg)0.900Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (High)0.910Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Low)0.890Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated Revenue)1Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated EPS)1Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in with Research Access to see up to 5 years of analyst estimates.

Create a free account

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
2.785B  ?P/S
 (TTM)
: 
0.22
?Net Income
 (TTM)
: 
-2.052B  ?P/E
 (TTM)
: 
-1.53
?Enterprise Value
 (TTM)
: 
3.521B  ?EV/FCF
 (TTM)
: 
-29.86
?Dividend Yield
 (TTM)
: 
0%  ?Payout Ratio
 (TTM)
: 
0%
?ROE
 (TTM)
: 
-20.13%  ?ROIC
 (TTM)
: 
-2.38%
?Net Debt
 (TTM)
: 
2.583B  ?Debt/Equity
 (TTM)
: 
1.74
?P/B
 (TTM)
: 
0.32  ?Current Ratio
 (TTM)
: 
1.36

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Log in — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Research Access for high/low estimates and the interactive table.

Forward P/E 1YResearch AccessResearch AccessResearch AccessResearch Access
12.42Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in with Research Access for forward P/E high/low estimates and the full multi-year table.

Create a free account

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

Based on current fundamentals and analyst forecasts, MarketSnap estimates QDEL intrinsic value between $14.42 – $17.54 per share. This depends on revenue growth, margins, and discount rate.

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.


Calculate QDEL Intrinsic Value

Common questions about QDEL valuation

Is QuidelOrtho Corporation (QDEL) overvalued or undervalued right now?

MarketSnap estimates intrinsic value for QuidelOrtho Corporation (QDEL) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is QDEL a buy, hold, or sell for long-term investors?

MarketSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether QDEL trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is QDEL’s P/E ratio?

You can see QDEL’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for QDEL?

MarketSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MarketSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is QDEL a good long-term investment?

Whether QDEL fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MarketSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

Research tools for QuidelOrtho Corporation

  • QuidelOrtho Corporation intrinsic value calculatorEstimate what the business is worth
  • QuidelOrtho Corporation 5-year outlookWhat has to go right, and what could go wrong
QDEL

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

-6.73
MarketSnap

Trading Metrics:

Open: 8.95   Previous Close: 8.92
Day Low: 8.06   Day High: 8.95
Year Low: 8.06   Year High: 35.58
Price Avg 50: 12.04   Price Avg 200: 15.01
Volume: 2.61M   Average Volume: 1.873M

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Log in — it's free
See in Nexus

Relevant news

QuidelOrtho Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of QuidelOrtho Corporation - QDEL
11-11-2026 13:38
QuidelOrtho Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of QuidelOrtho Corporation - QDEL
QuidelOrtho (QDEL) Securities Investigation Notice - Levi & Korsinsky
16-11-2026 10:01
QuidelOrtho (QDEL) Securities Investigation Notice - Levi & Korsinsky
Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving QuidelOrtho (QDEL)
12-11-2026 10:10
Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving QuidelOrtho (QDEL)
QuidelOrtho Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into QuidelOrtho (QDEL)
09-11-2026 17:35
QuidelOrtho Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into QuidelOrtho (QDEL)
QuidelOrtho Corporation (QDEL) Q3 2026 Earnings Call Transcript
04-11-2026 04:16
QuidelOrtho Corporation (QDEL) Q3 2026 Earnings Call Transcript
What QuidelOrtho (QDEL) Said on Its Q3 Earnings Call
03-11-2026 21:15
What QuidelOrtho (QDEL) Said on Its Q3 Earnings Call

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Pricing

How MarketSnap works

What’s new

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States

Language

    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
      • Large Caps
      • Absolute
      • Total Market PE
      • Large Caps
      • Absolute
      • Industry
      • Sector
    • Analyze a stockAnalyze QDEL →
    • FindStock Picks / Stock Screener
    • Value · QDELIntrinsic Value Calculator
    • Invest · QDELInvestment Case
    • Hold · QDEL5-Year Outlook
  • Learn
  • Calendar
  • Investment Compounding Calculator
    • Charts
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Investing Philosophy
  • Nexus
    • Recent Activity
      • Overview
      • My Valuations
      • My Investment Journal
      • Watchlists & Portfolio
    • Plans
    • Settings
    • Public profile ↗
  • Log in
  • Log out

Media

Watch Listen Read
Ask MarketSnap AI

MarketSnap AI Assistant

Uses MarketSnap data and this page

Ready

🔒 You are currently logged out

Login

It's free

MarketSnap Assistant · Tips
    MarketSnap

    Welcome to MarketSnap

    The AI-powered workspace for stock pickers.

    Continue with Google Continue with email

    Already a member? Sign in

    Find stocks·Value them·Build the case·Journal decisions·Track what changes

    Free to join. No card needed. Privacy Policy

    Create your free MarketSnap account Continue with Google
    Chat with us MarketSnap support · account, plans, settings, help
    How MarketSnap works

    The conversation above goes to the MarketSnap team with your message. We reply by e-mail.